AP NEWS

The Global Non-melanoma Skin Cancer (NMSC) Market (2018-2022) by Type of NMSC, Therapy and Region - ResearchAndMarkets.com

January 9, 2019

DUBLIN--(BUSINESS WIRE)--Jan 9, 2019--The “Global Non-melanoma Skin Cancer Market 2018-2022” report has been added to ResearchAndMarkets.com’s offering.

The non-melanoma skin cancer market will register a CAGR of almost 6% by 2022.

The latest trend gaining momentum in the market is the high off-label use of topical treatments for NMSC.

According to the report, one of the major drivers for this market is the rising incidence of NMSC across the globe, especially in Europe, the US, and Australia.

Further, the report states that one of the major factors hindering the growth of this market is the low data availability on NMSC statistics in cancer registries.

Key Players

Bausch Health F. Hoffmann-La Roche Sun Pharmaceuticals 3M Pharmaceuticals

Topics Covered

PART 01: EXECUTIVE SUMMARY

PART 02: SCOPE OF THE REPORT

PART 03: RESEARCH METHODOLOGY

PART 04: MARKET LANDSCAPE

Market ecosystem Market characteristics Market segmentation analysis

PART 05: PIPELINE ANALYSIS

PART 06: MARKET SIZING

PART 07: FIVE FORCES ANALYSIS

PART 08: MARKET SEGMENTATION BY TYPE OF NMSC

Segmentation by type of NMSC Comparison by type of NMSC BCC - Market size and forecast 2017-2022 SCC - Market size and forecast 2017-2022 Market opportunity by type of NMSC

PART 09: MARKET SEGMENTATION BY THERAPY

PART 10: CUSTOMER LANDSCAPE

PART 11: REGIONAL LANDSCAPE

Geographical Segmentation Regional comparison Americas - Market size and forecast 2017-2022 EMEA - Market size and forecast 2017-2022 APAC - Market size and forecast 2017-2022 Market opportunity

PART 12: DECISION FRAMEWORK

PART 13: DRIVERS AND CHALLENGES

PART 14: MARKET TRENDS

Increasing incidence of NMSC Surgery considered as a first-line curative approach for NMSC High off-label use of topical treatments for NMSC Low physician adherence to NMSC diagnostic and treatment guidelines

PART 15: VENDOR LANDSCAPE

PART 16: VENDOR ANALYSIS

Vendors covered Vendor classification Market positioning of vendors Bausch Health F. Hoffmann-La Roche Sun Pharmaceuticals 3M Pharmaceuticals

For more information about this report visit https://www.researchandmarkets.com/research/wjv5vf/the_global?w=4

View source version on businesswire.com:https://www.businesswire.com/news/home/20190109005643/en/

CONTACT: ResearchAndMarkets.com

Laura Wood, Senior Press Manager

press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

Related Topics:Skin Cancer Drugs

KEYWORD:

INDUSTRY KEYWORD: HEALTH ONCOLOGY PHARMACEUTICAL

SOURCE: Research and Markets

Copyright Business Wire 2019.

PUB: 01/09/2019 11:39 AM/DISC: 01/09/2019 11:38 AM

http://www.businesswire.com/news/home/20190109005643/en

AP RADIO
Update hourly